RHO Day Webinar
Friday, November 6, 2026, 10:00 a.m. – 12:15 p.m. (EDT)
Join the global RHO-adRP community for a live, interactive virtual gathering for patients, families, clinicians, and industry partners.
Get updates on Foundation Event
Location
Virtual
This session brings together clinical experts, genetic specialists, and biotech pioneers to explore Rhodopsin mediated autosomal dominant retinitis pigmentosa.
Key Topics
- Disease progression & the patient journey
- Genetic testing & autosomal-dominant inheritance
- Clinical trial participation & patient resources
- Emerging industry research pipelines
- Live audience Q&A
Featured Speakers
- Jason Comander, MD, PhD (Director, Inherited Retinal Disorders Service, Mass Eye & Ear) – RHO disease overview
- Kari Branham, MS, CGC (Director of Ophthalmic Genetic Counseling, Kellogg Eye Center, Univ. of Michigan) – Genetics & testing
- Mary & Lara Findlay – RHO-adRP family perspective
- Todd Durham, PhD (SVP, Clinical & Outcomes Research, Foundation Fighting Blindness) – Clinical trials & resources
- Alicia Kemble, PhD (Principal, Gund Vision Fund) – Moderator
Industry Pipeline Presenters
- Matthew Albert, MD, PhD – VP, Early Clinical Development, Octant
- Sally Tucker, PhD – Chief Medical Officer, Opus Genetics
- Kali Stasi, MD, PhD – Chief Medical Officer, SparingVision
- Beth Scott, OD, MS – VP, Clinical Development, Ocugen
- Emily Brown, PhD – Associate Director, Clinical Development, Ophthalmology, BlueRock Therapeutics
Register to receive your meeting link and connect with the global community. All registrants receive session recordings and materials post-event. For questions, contact Grace Warner at GraceWarner@GundVisionFund.org
